Section 14.1
Potassium & Sodium Homeostasis
Explain how potassium and sodium support excitable cells, distinguish cardiac protection, intracellular potassium shifting and potassium removal in hyperkalemia, and apply safe replacement and monitoring principles.
Learn
Idea 1 / 4
Electrolytes are gradients, not just laboratory numbers
Sodium is the main extracellular cation and helps determine extracellular-fluid tonicity and volume. Potassium is mainly intracellular; the difference between extracellular and intracellular potassium helps set the resting membrane potential. A meaningful change in either can therefore alter nerve and muscle excitability, including cardiac conduction. Interpret a result with symptoms, volume status, kidney function, medicines and an electrocardiogram (ECG) when clinically indicated—not as an isolated number.
A potassium result obtained during vomiting has a different safety context from the same result in a stable person with advanced kidney disease and potassium-retaining medicines.
Read all essential notes
Electrolytes are gradients, not just laboratory numbers
Sodium is the main extracellular cation and helps determine extracellular-fluid tonicity and volume. Potassium is mainly intracellular; the difference between extracellular and intracellular potassium helps set the resting membrane potential. A meaningful change in either can therefore alter nerve and muscle excitability, including cardiac conduction. Interpret a result with symptoms, volume status, kidney function, medicines and an electrocardiogram (ECG) when clinically indicated—not as an isolated number.
A potassium result obtained during vomiting has a different safety context from the same result in a stable person with advanced kidney disease and potassium-retaining medicines.
Hyperkalemia treatment has separate jobs
In clinically significant hyperkalemia, a monitored emergency pathway separates three goals. Calcium may protect the myocardium when ECG changes indicate cardiac toxicity; it does not lower total body potassium. Insulin with glucose, and sometimes a beta-2 agonist, move potassium into cells and buy time, but do not remove potassium from the body. A durable plan also addresses removal and the cause—such as impaired renal excretion, acidosis, tissue breakdown or a contributing medicine—while repeatedly reassessing potassium, glucose and the ECG as appropriate.
After insulin–glucose lowers a dangerous serum potassium concentration, rebound remains possible if the potassium has not been removed or its cause has not been corrected.
Potassium replacement requires controlled safeguards
Potassium chloride (KCl) corrects potassium deficit, but a concentrated intravenous potassium product must never be pushed from a syringe. Product labeling requires dilution and controlled intravenous infusion; route, concentration, rate, cardiac monitoring and repeat measurements depend on severity, renal function and the institution’s protocol. Oral replacement may be suitable in selected people who can use it safely, but a learner must not convert this principle into a self-directed dose change.
A prescribed KCl concentrate found in a medication area is not an emergency bolus: pause, verify the order and use the prepared infusion process.
Low sodium has a cause; saline is not a universal answer
A low serum sodium concentration can occur with reduced extracellular volume, excess water relative to solute, endocrine disease, kidney disease or medicines. The safe first question is not simply “which saline?” but whether the person has severe symptoms, what the tonicity and volume state are, and what caused the imbalance. Sodium chloride solutions replenish sodium and fluid, yet can worsen fluid overload or sodium retention in susceptible people. Hypertonic saline and concentrated sodium products require protocol-led monitored use; rapid or indiscriminate correction can harm the patient.
Vomiting with low blood pressure and low sodium suggests volume depletion, whereas a low sodium result in fluid-overloaded heart failure needs a different clinician-directed assessment.
Common misconception: “Insulin fixes hyperkalemia” is incomplete. Insulin temporarily shifts potassium into cells and can cause hypoglycemia; it neither removes total body potassium nor replaces monitoring and cause-directed treatment.
Explore
Interactive mechanism plate · 14.1
Hyperkalemia treatment has three separate jobs
Trace cardiac protection, temporary intracellular shifting and potassium removal. The sequence is a monitored emergency framework, not a dosing protocol.
More controls
1 / 4 · High extracellular K⁺ can disturb cardiac conduction · Schematic, not to scale; arrows show a causal teaching sequence.
Reduced motion is on: use the step controls to inspect each causal change.
Go deeper: worked example
A person with chronic kidney disease taking a renin–angiotensin system medicine reports new weakness. Their potassium is high and the ECG has changes concerning for hyperkalemia.
- Recognize this as a monitored clinical emergency: symptoms, potassium result, kidney disease and ECG evidence together matter more than any one feature alone.
- Separate the immediate goals: a clinician may use calcium to protect the heart when indicated, a potassium-shifting treatment to gain time, and a plan that actually removes potassium and addresses the cause.
- Monitor potassium and blood glucose after insulin-based shifting treatment, reassess the ECG and review renal function and contributing medicines. Escalate according to the local emergency pathway; do not improvise doses from a lesson.
Calcium protection, intracellular shifting and potassium removal answer different clinical questions. Treating only one can leave the person at risk.
Explain it yourself
Why can potassium fall after insulin–glucose treatment and then rise again later?
Reveal explanation
Insulin redistributes potassium from extracellular fluid into cells. If impaired excretion, ongoing release or another cause persists, total body potassium has not necessarily fallen and rebound can occur after the shifting effect wanes.
Create and evaluate
Create a one-page handoff plan for a patient with an electrolyte abnormality. It must distinguish immediate danger, the proposed mechanism-directed intervention, monitoring and the unresolved cause; use a clinician-approved local protocol rather than inventing doses.
Formative activity: compare your reasoning with the rubric. This response is not automatically graded and does not award mastery. It remains only on this page and is cleared when you leave.
Compare with the rubric and example
- States symptoms, ECG/clinical danger signals, electrolyte trend, kidney function, volume state and relevant medicines.
- Separates cardiac protection, redistribution, replacement or removal, and explains what each action cannot do.
- Names protocol-directed monitoring and a plan to investigate or correct the cause without self-prescribing.
For hyperkalemia with ECG changes, document the ECG concern, potassium trend, renal function and contributing medicines; record that calcium, if indicated, protects the heart while insulin–glucose shifts potassium and does not remove it; follow the local pathway for serial potassium, glucose and ECG checks; and document the plan to address impaired excretion or a contributing medicine. Escalate to the responsible clinician rather than calculating a dose independently.
Sources and review status
Educational draft. Medical and French-language expert review pending. External sources require an internet connection; essential explanations are included above.
- UK Kidney Association: Management of Hyperkalaemia in Adults (updated July 2026)
Hospital algorithm: ECG assessment, cardiac protection, potassium shifting/removal and post-treatment potassium and glucose monitoring
- DailyMed: MYXREDLIN (insulin human) prescribing information
Warnings and Precautions 5.2 and 5.4: hypoglycemia and extracellular-to-intracellular potassium shift
- DailyMed: Potassium Chloride for Injection Concentrate prescribing information
Concentrate must be diluted before use; intravenous infusion only
- DailyMed: Sodium Chloride Injection prescribing information
Fluid/electrolyte monitoring, sodium retention and fluid-overload precautions
- European Society of Endocrinology: Clinical Practice Guideline on diagnosis and treatment of hyponatraemia
Diagnostic assessment by tonicity and extracellular-volume state; cause-specific treatment, monitored correction and volume restoration in reduced circulating volume
Check my understanding
Mastery Question Gate
Answer all questions correctly to unlock the next lesson. Retakes vary the selection when enough questions are available; some questions may repeat.
1. Why is direct IV push infusion of concentrated Potassium Chloride (KCl) strictly prohibited?